Molecular Devices Home
Careers  |  Contact Us  |  Search:   

  

2002 MDC 6th International Drug Discovery Conf.

This year's International Drug Discovery Conference was a huge success, thanks to all of our presenters! The presentation topics are listed below. For those presentations having a downloadable (pdf) version, we have indicated the file size of the pdf.

screening protein kinases using IMAP®

  • Tyrosine Kinases as Drug Targets; their History, Diseases and Difficulties (with Special Reference to Gleevac). Future Discovery Trends in Research and the Next Generation of Kinase Drug Targets
    Tom Roberts, Ph.D., Chair, Harvard Medical School
  • Screening for Inhibitors of MAPKAP2, a Serine-Threonine Kinase, Using IMAP
    James P. O'Connell, Ph.D., Celltech

    Download presentation  [PDF]  (870 K)

  • Application of IMAP Technology to p38a Protein Kinase
    Bonnie L. Bertolaet, Ph.D., Triad Therapeutics

    Download abstract  [PDF] 
    Download presentation  [PDF]  (520 K)

  • Screening for Tyrosine and Serine-Threonin Kinase Inhibitors: Validation and Application of IMAP Technology and Specificity Testing of HTS Hits
    Jason Peter Brown, Ph.D., Upstate

    Download abstract  [PDF] 
    Download presentation  [PDF]  (690 K)



target validation using homogenous assays

  • Experiences with Fluorescence Methods in Ultra High-throughput Screening and Drug Discovery Using the Analyst™
    Michael K. Helms,Ph.D., Exelixis, Inc.

    Download abstract  [PDF] 
    Download presentation  [PDF]  (870 K)

  • Characterizing the Kinetics of Receptor-Antagonist Interactions Using a Fluorescence Polarization Competition Method on a Plate Reader
    Susan M. Keating, Ph.D., Genentech, Inc.

    Download abstract  [PDF] 

  • Characterization of the 5-HT6 Receptor using CatchPoint™ cAMP Assay: Comparison with FP and FlashPlate™
    Martyn D, Wood, Ph.D., GlaxoSmithKline

    Download abstract  [PDF] 
    Download presentation  [PDF]  (2.0 MB)



ion channels by electrophysiology

  • Ion Channels in Drug Safety and Drug Discovery
    Arthur M. Brown, M.D., Ph.D., ChanTest, Inc.

    Download abstract  [PDF] 
    Download presentation  [PDF]  (2.8 MB)

  • IonWorks™ APC: Automated Patch Clamp Electrophysiology on Silicon-Based Planar Substrates
    Christian Schmidt, Ph.D., Cytion, S.A.

    Download abstract  [PDF] 

  • IonWorks™ HT: High-throughput Patch Clamp Electrophysiology
    Wilhelm G. Lachnit, Ph.D., Molecular Devices

    Download abstract  [PDF] 



ion channels on FLIPR® and FlexStation™

  • Application of FLIPR® to the Evaluation of Mechanisms of Action of Novel Neurotoxins: Ion Channels as Molecular Targets
    Thomas F. Murray, Ph.D., University of Georgia, College of Veterinary Medicine

    Download abstract  [PDF] 
    Download presentation  [PDF]  (1.1 MB)

  • Characterization of Recombinant and Native Voltage-Gated Sodium Channels (VGSCs) Using Membrane Potential- or Calcium-Sensitive Dyes
    Jerri H. Martin, Theravance, Inc.

    Download abstract  [PDF] 

  • Using the FlexStation™ to Investigate Voltage-Gated Calcium and Sodium Channels
    Stuart D. C. Ward, Ph.D., Ionix Pharmaceuticals, Ltd.

    Download abstract  [PDF] 
    Download presentation  [PDF]  (290 K)

  • Application of Molecular Devices' Fluorescence Membrane Potential Sensitive Dye for the Study of a Human Electrogenic Transporter
    Giorgia Michela Stucchi, Ph.D., Axxam

    Download abstract  [PDF] 
    Download presentation  [PDF]  (1 MB)

  • Progress Toward a High-throughput Assay for a hERG Channel Blocker
    Byron Taylor, Amgen

    Download abstract  [PDF] 
    Download presentation  [PDF]  (660 K)



screening on FLIPR®

  • Improved FLIPR® HTS for a Chemokine GPCR Using the Molecular Devices Calcium Plus Reagent Kit
    Ralph J. Garippa, Ph.D., Hoffman-La Roche

    Download abstract  [PDF] 
    Download presentation  [PDF]  (550 K)

  • Development and Validation of a High-throughput Cell-based Screen for a Chemokine Receptor Using FLIPR® and the Calcium Plus Kit
    Sofia Ribeiro, Ph.D., Berlex Laboratories, Inc.

    Download abstract  [PDF] 

  • 1536-well FLIPR®: A Possibility or Probability?
    Gary Allenby, Ph.D., AstraZeneca

    Download abstract  [PDF] 
    Download presentation  [PDF]  (1 MB)

  • FLIPR®-based Assay for Screening Inhibitors of the Multidrug Resistance Gene MDR1 in vitro
    Vee Mitchell, GlaxoSmithKline

    Download abstract  [PDF] 
    Download presentation  [PDF]  (900 K)

  • AptuScreen: A Novel Real-Time cAMP Assay for FLIPR®
    Yong Yao, Aptus Genomics